Publication & Citation Trends
Publications
127 total
Abstract PS4-07-06: Independent validation of TNBCDX, a 15-gene genomic risk stratification tool for early-stage triple-negative breast cancer
Cited by 0
Semantic Scholar
Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane
Cited by 0
Semantic Scholar
Abstract PS5-01-23: Validation of the HER2DX Genomic Test in First-Line Advanced HER2-Positive Breast Cancer: Identifying Long-Term Responders to THP
Cited by 0
Semantic Scholar
Abstract PS3-10-24: Biologic and Pathologic Correlations of the HER2DX Genomic Test in HER2+ Disease
Cited by 0
Semantic Scholar
Abstract PS4-02-23: Biomarkers of response and resistance to Sacituzumab Govitecan in HR+/HER2− advanced breast cancer: interim results from the phase II SOLTI ACROSS-TROP2 Trial
Cited by 0
Semantic Scholar
Abstract 6752: Mapping the spatial organisation of B cells and immune signalling in TNBC to characterise response to immunotherapy
Cited by 0
Semantic Scholar
Abstract PD2-07: Multi-omics characteristics of ER+/HER2- breast cancer switching to metastatic non-luminal subtype: findings from the AURORA study (BIG14-01)
Cited by 0
Semantic Scholar
Abstract RF4-01: Central Nervous System Outcomes from the Phase III PATINA Trial (AFT-38)
Cited by 0
Semantic Scholar
Research Topics
Advanced Breast Cancer Therapies
(88)
Cancer Treatment and Pharmacology
(61)
HER2/EGFR in Cancer Research
(52)
Breast Cancer Treatment Studies
(24)
PI3K/AKT/mTOR signaling in cancer
(17)
Affiliations
Université Paris-Sud
Roche (Switzerland)
Indiana University Health
MedStar Washington Hospital Center
University of Udine